Avadel Pharmaceuticals (AVDL) Non Operating Income (2016 - 2020)
Historic Non Operating Income for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Q2 2020 value amounting to -$125000.0.
- Avadel Pharmaceuticals' Non Operating Income fell 15000.0% to -$125000.0 in Q2 2020 from the same period last year, while for Mar 2021 it was -$125000.0, marking a year-over-year increase of 6719.16%. This contributed to the annual value of -$435000.0 for FY2020, which is 1507.94% down from last year.
- According to the latest figures from Q2 2020, Avadel Pharmaceuticals' Non Operating Income is -$125000.0, which was down 15000.0% from -$310000.0 recorded in Q1 2020.
- In the past 5 years, Avadel Pharmaceuticals' Non Operating Income ranged from a high of $1.7 million in Q2 2017 and a low of -$2.8 million during Q2 2016
- Its 5-year average for Non Operating Income is -$188388.9, with a median of -$132000.0 in 2019.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Non Operating Income soared by 16022.36% in 2017, and later crashed by 17181.82% in 2018.
- Avadel Pharmaceuticals' Non Operating Income (Quarter) stood at -$413000.0 in 2016, then crashed by 122.03% to -$917000.0 in 2017, then surged by 150.93% to $467000.0 in 2018, then crashed by 74.73% to $118000.0 in 2019, then crashed by 205.93% to -$125000.0 in 2020.
- Its Non Operating Income was -$125000.0 in Q2 2020, compared to -$310000.0 in Q1 2020 and $118000.0 in Q4 2019.